Craft
BioNano Genomics

BioNano Genomics

Revenue

$18 M

FY, 2021

Market Capitalization

$737 M

2022-09-12

BioNano Genomics Summary

Company summary

Overview
BioNanomatrix develops nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The Company's technology provides analysis of genomic, epigenomic, and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine, and biomedical research applications. 
Type
Public
Status
Active
Founded
2002
HQ
San Diego, CA, US | view all locations
Website
http://bionanogenomics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Erik Holmlin

    Erik Holmlin, President, Chief Executive Officer and Director

  • David L. Barker, Chairman

    • Mark Oldakowski

      Mark Oldakowski, Chief Operating Officer

      • Christopher J. Twomey, Director

        LocationsView all

        3 locations detected

        • San Diego, CA HQ

          United States

          9640 Towne Centre Dr #100

        • Kayseri

          Turkey

          Tacettin Veli, Deliklitaş Cd. 12a

        • London, England

          United Kingdom

          90 Fetter Ln, Holborn

        BioNano Genomics Financials

        Summary financials

        Revenue (Q3, 2022)
        $7.2M
        Gross profit (Q3, 2022)
        $1.8M
        Net income (Q3, 2022)
        ($31.8M)
        Cash (Q3, 2022)
        $28.2M
        EBIT (Q3, 2022)
        ($32.1M)
        Enterprise value
        $718.9M

        Footer menu